Annual report pursuant to Section 13 and 15(d)

SHARE-BASED COMPENSATION

v3.22.4
SHARE-BASED COMPENSATION
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
SHARE-BASED COMPENSATION SHARE-BASED COMPENSATION
Share-based awards are eligible for issuance under the Huntington Bancshares Incorporated 2018 Long Term Incentive Plan. This plan provides for the granting of stock options, restricted stock awards, restricted stock units, performance share units and other awards to officers, directors, and other employees. In connection with the TCF acquisition in 2021, equity awards granted under the TCF equity plans were assumed subject to the same terms and conditions applicable to such awards prior to the date of acquisition. At December 31, 2022, 21 million shares were available for future grants.
Huntington issues shares to fulfill share-based award vesting from available authorized common shares. At December 31, 2022, Huntington believes there are adequate authorized common shares to satisfy anticipated share-based award vesting in 2023.
The following table presents total share-based compensation expense and related tax benefit.
Year Ended December 31,
(dollar amounts in millions) 2022 2021 2020
Share-based compensation expense (1) $ 119  $ 138  $ 77 
Tax benefit 20  22  13 
(1)Compensation costs are included in personnel costs on the Consolidated Statements of Income.
Stock Options
Stock options, awarded by Huntington, are granted at the closing market price on the date of the grant and vest ratably over four years or when other conditions are met. Options assumed in the TCF acquisition vest ratably over a five-year period. Stock options, which represented a portion of the grant values, have no intrinsic value until the stock price increases. All options have a contractual term of ten years from the date of grant.
Huntington’s stock option activity and related information was as follows:
(dollar amounts in millions, except per share and options amounts in thousands) Options Weighted-
Average
Exercise Price
Weighted-Average
Remaining
Contractual Life (Years)
Aggregate
Intrinsic Value
Outstanding at January 1, 2022 14,466  $ 12.34 
Granted 74  15.54 
Exercised (912) 10.08 
Forfeited/expired (170) 13.20 
Outstanding at December 31, 2022 13,458  $ 12.50  6.0 $ 28 
Expected to vest (1) 4,076  $ 12.09  7.5 $ 11 
Exercisable at December 31, 2022 9,336  $ 12.68  5.3 $ 17 
(1)The number of options expected to vest reflect an estimate of 46,000 shares expected to be forfeited.
Restricted Stock Awards, Restricted Stock Units and Performance Share Units
Restricted stock units and performance share units awarded by Huntington are granted at the closing market price on the date of the grant. Restricted stock units and awards can be settled in shares or cash depending on the award. Restricted stock units, for the most part, provide either accumulated cash dividends during the vesting period or, accrue a dividend equivalent that is paid upon vesting. Both restricted stock awards and restricted stock units are subject to certain service restrictions. Performance share units are payable contingent upon Huntington achieving certain predefined performance objectives over a three-year measurement period. The fair value of these awards and units reflects the closing market price of Huntington’s common stock on the grant or assumption date.
The following table summarizes the status of Huntington’s restricted stock awards, restricted stock units, and performance share units as of December 31, 2022, and activity for the year ended December 31, 2022:
Restricted Stock Awards Restricted Stock Units Performance Share Units
(amounts in thousands, except per share amounts) Quantity
Weighted-
Average
Grant Date
Fair Value
Per Share
Quantity
Weighted-
Average
Grant Date
Fair Value
Per Share
Quantity
Weighted-
Average
Grant Date
Fair Value
Per Share
Nonvested at January 1, 2022 356  $ 14.46  19,098  $ 12.85  3,126  $ 12.06 
Granted —  —  12,592  13.37  1,743  14.39 
Vested (212) 14.72  (5,848) 14.31  (1,342) 13.72 
Forfeited (20) 14.39  (1,621) 12.69  (58) 13.50 
Nonvested at December 31, 2022 124  $ 14.37  24,221  $ 12.70  3,469  $ 12.40 
The weighted-average fair value at grant date of nonvested shares granted for the years ended December 31, 2022, 2021, and 2020 were $13.47, $15.78, and $8.90, respectively. The total fair value of awards vested during the years ended December 31, 2022, 2021, and 2020 was $105 million, $135 million, and $86 million, respectively. As of December 31, 2022, the total unrecognized compensation cost related to nonvested shares was $151 million with a weighted-average expense recognition period of 2.7 years.